Virginia Healthcare Press: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Virginia Healthcare Press.

Press releases published on May 26, 2026

7 hours ago

Behavioral Health Services of Virginia Enters New Chapter Focused on Service Quality, Stability, and Community Impact

Indeterminate EIN Presswire

39 minutes ago

Kane Biotech Announces the Oversubscription and Closing of Private Placement Offering

Indeterminate GlobeNewswire

an hour ago

NervGen Announces Positive Independent, Blinded Biomechanical Gait Analyses Demonstrating Genuine Neural Recovery with NVG-291 in Phase 1b/2a CONNECT SCI Study

Indeterminate GlobeNewswire

an hour ago

Cartesian Therapeutics Secures up to $150 Million of Non-Dilutive Financing from K2 HealthVentures and Expects Topline Data from the Phase 3 AURORA Trial in First Quarter 2027

Indeterminate GlobeNewswire

an hour ago

Olema Oncology Announces Clinical Trial Collaboration and Supply Agreement with Bayer to Evaluate OP-3136 in Combination with NUBEQA® (darolutamide) in Metastatic Castration-Resistant Prostate Cancer

Indeterminate GlobeNewswire

an hour ago

Outlook Therapeutics Wins Appeal Following Formal Dispute Resolution Process for ONS-5010/LYTENAVA™ (bevacizumab-vikg)

Indeterminate GlobeNewswire

an hour ago

Tonix Pharmaceuticals Presented Retrospective U.S. Real-World Claims Analysis Characterizing Patients with Fibromyalgia at The Professional Society for Health Economics and Outcomes Research (ISPOR) 2026 Annual Meeting

Indeterminate GlobeNewswire

an hour ago

Jade Biosciences Announces First Participant Dosed in Phase 2 JUNIPER Clinical Trial of JADE101 in IgA Nephropathy

Indeterminate GlobeNewswire

an hour ago

Diasome to Present Phase 2b Results from OPTI-2 Trial Evaluating HDV-Insulin Lispro in Type 1 Diabetes at ADA 86th Scientific Sessions

Indeterminate GlobeNewswire

an hour ago

Spectral AI Receives FDA De Novo Clearance for DeepView® System for Burn Indication

Indeterminate GlobeNewswire

an hour ago

Corbus Pharmaceuticals Reports Updated CRB-701 Phase 1/2 Clinical Data Demonstrating Robust Activity in 2L Oropharyngeal and Cervical Cancers

Indeterminate GlobeNewswire

an hour ago

Climb Bio to Present on CLYM116 and Budoprutug Programs at European Renal Association (ERA) Congress 2026

Indeterminate GlobeNewswire

an hour ago

Cullinan Therapeutics to Host Immunology Day to Showcase Promising Initial Clinical Data in Autoimmune Diseases for CLN-978, a CD19 T Cell Engager, and Velinotamig, a BCMA T Cell Engager

Indeterminate GlobeNewswire

an hour ago

Axsome Therapeutics Presents New AUVELITY® Data in Major Depressive Disorder at the American Society of Clinical Psychopharmacology (ASCP) 2026 Annual Meeting

Indeterminate GlobeNewswire

an hour ago

Curevo to be Acquired by Lilly to Advance Next-Generation Shingles Prevention

Indeterminate GlobeNewswire

2 hours ago

Nxera’s President & CEO to Participate in a ‘Fireside Chat’ at the Jefferies New York Healthcare Conference 2026

Indeterminate GlobeNewswire

2 hours ago

Editas Medicine Announces Proposed Public Offering

Indeterminate GlobeNewswire

2 hours ago

Kura Oncology Reports Strong Clinical Activity and Safety with Darlifarnib + Adagrasib in KRAS G12C-Mutated Solid Tumors

Indeterminate GlobeNewswire

2 hours ago

Editas Medicine Presents EDIT-401 Preclinical Data Demonstrating Robust Reductions in LDL-C, Lp(a), and ApoB in Non-Human Primates at the 94th European Atherosclerosis Society Congress

Indeterminate GlobeNewswire

2 hours ago

New study finds over a third of young men at risk of gambling related harm; fathers disproportionately affected

Indeterminate GlobeNewswire